title: [Are there specific treatments for allergic asthma?].
authors.affiliation: Clinique des Voies Respiratoires, CHU de Toulouse, hôpital Larrey, Toulouse.
authors.forename: A
authors.initials: A
authors.lastname: Didier
authors.forename: F
authors.initials: F
authors.lastname: De Blay
authors.forename: L
authors.initials: L
authors.lastname: Tetu
authors.forename: J C
authors.initials: JC
authors.lastname: Dubus
authors.forename: A
authors.initials: A
authors.lastname: Grimfeld
authors.forename: J
authors.initials: J
authors.lastname: Just
authors.forename: P
authors.initials: P
authors.lastname: Demoly
mesh_terms: D000279:Administration, Cutaneous; D000286:Administration, Sublingual; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000628:therapy*; D002986:Clinical Trials as Topic; D003888:Desensitization, Immunologic / Q000379:methods*; D006801:Humans; D000069444:Omalizumab; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D012221:Rhinitis, Allergic, Perennial / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab